Gap Fund: single-step support for medical product development (Grant)

Apply to the MRC 'Gap Fund' for single-step support in developing a new or repurposed medicine, medical device, diagnostic, or other medical product. Projects must target a high-risk development step backed by prior funding, generating critical data to de-risk onward progression or determine failure. The 'Gap Fund' strategically bridges the smaller Impact Acceleration Account (IAA) and the larger Developmental Pathway Funding Scheme (DPFS). This funding opportunity provides small scale funding to generate critical data needed prior to seeking more substantive funding. Examples of supported projects include high-risk elements of therapeutic discovery, quantification and validation, high-risk stages of prototype development, early prototype testing, initial biomarker validation, vector identification or optimisation, and hit expansion medicinal chemistry. Applicants must be based at a Medical Research Council (MRC) eligible research organisation.